Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $408.0100 (0.37%) ($402.0200 - $408.9500) on Thu. Sep. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.9% (three month average) | RSI | 58 | Latest Price | $408.0100(0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(45%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -0.95% in a week (0% probabilities). VIXM(-9%) TLT(-8%) UUP(-7%) SHY(-3%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.95% (StdDev 1.9%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
5 Day Moving Average | $406.45(0.38%) | 10 Day Moving Average | $401.14(1.71%) | 20 Day Moving Average | $399.18(2.21%) | To recent high | -7.6% | To recent low | 23.2% | Market Cap | $43.261b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |